Press Releases
// Jul 25, 2019
Massachusetts General Hospital and ElevateBio Announce a 10-Year Alliance Agreement to Utilize ElevateBio BaseCamp to Manufacture Innovative Cell and Gene Therapies
// Jun 11, 2019
AlloVir Announces Viralym-M Granted Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Hemorrhagic Cystitis Caused by BK Virus in Adults and Children Following Allogeneic HSCT
// May 22, 2019
ElevateBio announces that Allovir joins its portfolio of highly innovative cell and gene therapy companies
// May 13, 2019
